Literature DB >> 19038526

Organizational determinants of outpatient substance abuse treatment duration in women.

Cynthia I Campbell1, Jeffrey A Alexander, Christy Harris Lemak.   

Abstract

Longer treatment duration has consistently been related to improved substance use outcomes. This study examined how tailored women's programming and organizational characteristics were related to duration in outpatient substance abuse treatment in women. Data were from two waves of a national outpatient substance abuse treatment unit survey (n = 571 in 1999/2000, n = 566 in 2005). Analyses were conducted separately for methadone and nonmethadone programs. Negative binomial regressions tested associations between organizational determinants, tailored programming, and women's treatment duration. Of the tailored programming services, childcare was significantly related to longer duration in the nonmethadone programs, but few other organizational factors were. Tailored programming was not associated to treatment duration in methadone programs, but ownership, affiliation, and accreditation were related to longer duration. Study findings suggest evidence for how external relationships related to resources, treatment constraints, and legitimacy may influence women's treatment duration. Methadone programs may be more vulnerable to external influences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038526      PMCID: PMC2935286          DOI: 10.1016/j.jsat.2008.09.012

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  38 in total

1.  Managed care and outpatient substance abuse treatment intensity.

Authors:  C H Lemak; J A Alexander
Journal:  J Behav Health Serv Res       Date:  2001-02       Impact factor: 1.505

2.  Changes in methadone treatment practices: results from a panel study, 1988-1995.

Authors:  T D'Aunno; N Folz-Murphy; X Lin
Journal:  Am J Drug Alcohol Abuse       Date:  1999-11       Impact factor: 3.829

3.  The organization of substance abuse managed care.

Authors:  M R Sosin; T D'Aunno
Journal:  Recent Dev Alcohol       Date:  2001

4.  Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005.

Authors:  Jeffrey A Alexander; Tammie A Nahra; Christy Harris Lemak; Harold Pollack; Cynthia I Campbell
Journal:  J Subst Abuse Treat       Date:  2007-06-28

5.  Gender differences in problem severity at assessment and treatment retention.

Authors:  C L Arfken; C Klein; S di Menza; C R Schuster
Journal:  J Subst Abuse Treat       Date:  2001-01

6.  The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine.

Authors:  M Galanter; D S Keller; H Dermatis; S Egelko
Journal:  J Addict Dis       Date:  2000

7.  Predictors of outpatient treatment retention: patient versus substance use characteristics.

Authors:  M E McCaul; D S Svikis; R D Moore
Journal:  Drug Alcohol Depend       Date:  2001-03-01       Impact factor: 4.492

Review 8.  Women and alcohol use disorders.

Authors:  Shelly F Greenfield
Journal:  Harv Rev Psychiatry       Date:  2002 Mar-Apr       Impact factor: 3.732

9.  Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders.

Authors:  Rudolf H Moos; Bernice S Moos
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

10.  Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.

Authors:  Carla A Green; Michael R Polen; Daniel M Dickinson; Frances L Lynch; Marjorie D Bennett
Journal:  J Subst Abuse Treat       Date:  2002-12
View more
  11 in total

1.  The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.

Authors:  Maria Paino; Lydia Aletraris; Paul Roman
Journal:  J Stud Alcohol Drugs       Date:  2016-01       Impact factor: 2.582

Review 2.  Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Am J Addict       Date:  2019-05-26

3.  Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.

Authors:  Erick G Guerrero; Julie A Cederbaum
Journal:  Int J Drug Policy       Date:  2010-10-20

4.  Organizational characteristics that foster early adoption of cultural and linguistic competence in outpatient substance abuse treatment in the United States.

Authors:  Erick G Guerrero
Journal:  Eval Program Plann       Date:  2012-02

5.  Systematic review of sex-based differences in opioid-based effects.

Authors:  Andrew S Huhn; Meredith S Berry; Kelly E Dunn
Journal:  Int Rev Psychiatry       Date:  2018-12-06

6.  Child care in outpatient substance abuse treatment facilities for women: findings from the 2008 National Survey of substance Abuse Treatment Services.

Authors:  Jonathan David Brown; Sonya Vartivarian; Cathie E Alderks
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

7.  Substance abuse and batterer programmes in California, USA: factors associated with treatment outcomes.

Authors:  Christine Timko; Helen Valenstein; Gregory L Stuart; Rudolf H Moos
Journal:  Health Soc Care Community       Date:  2014-12-03

8.  Organizational capacity for service integration in community-based addiction health services.

Authors:  Erick G Guerrero; Gregory A Aarons; Lawrence A Palinkas
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

9.  Gender Comparison in Referrals and Treatment Completion to Residential and Outpatient Alcohol Treatment.

Authors:  Shahrzad Bazargan-Hejazi; Valory De Lucia; Deyu Pan; Mona Mojtahedzadeh; Elham Rahmani; Sinan Jabori; Golara Zahmatkesh; Mohsen Bazargan
Journal:  Subst Abuse       Date:  2016-12-19

Review 10.  Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS.

Authors:  Allison J Carter; Sonya Bourgeois; Nadia O'Brien; Kira Abelsohn; Wangari Tharao; Saara Greene; Shari Margolese; Angela Kaida; Margarite Sanchez; Alexis K Palmer; Angela Cescon; Alexandra de Pokomandy; Mona R Loutfy
Journal:  J Int AIDS Soc       Date:  2013-01-11       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.